Over two thirds of marketed recombinant biopharmaceutical products are glycoproteins, and regulatory agencies require the use of state-of-the-art glycan analysis methods for the development and commercialization of safe and effective glycosylated biotherapeutics.
Waters can help improve the quality of your glycan analysis and reduce sample prep time with easy to use workflow-based approaches, transforming what had once been a specialized and complicated activity into one in which scientists of any skill level can be successful. Our solutions span the entire development cycle— from released glycan monitoring and characterization, to glycoprotein profiling, middle-up/down, subunit analysis, monosaccharide and sialic acid composition, and glycopeptide mapping. Partner with Waters for the latest advancements to keep your lab compliant, accelerate your decision-making, and advance molecules to the clinic faster.
Demo: Glycan Analysis Workflow with Andrew+ Pipetting Robot